| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 38,582 | 37,052 | 27,794 | 40,851 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 38,582 | 37,052 | 27,794 | 40,851 | | | Operating Expenses | | Research Development | 9,591 | 11,234 | 11,005 | 16,902 | | Selling General and Administrative | 15,147 | 14,775 | 14,223 | 19,757 | | Non Recurring | 15 | 44 | 10,627 | 22,662 | | Others | 1,574 | 1,570 | 1,593 | 1,665 | | | | Total Operating Expenses | 26,327 | 27,623 | 37,448 | 60,986 | | | | Operating Income or Loss | 12,284 | 9,429 | (9,654) | (20,135) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 987 | (365) | 2,856 | (4,627) | | Earnings Before Interest And Taxes | (6,599) | 9,064 | (6,798) | (24,762) | | Interest Expense | (13,118) | 6,701 | 6,417 | 6,825 | | Income Before Tax | 6,519 | 2,363 | (13,215) | (31,587) | | Income Tax Expense | 1,976 | 1,904 | (2,269) | (3,279) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,543 | 459 | (10,946) | (28,308) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,543 | 459 | (10,946) | (28,308) | | Preferred Stock And Other Adjustments | (2,482) | (2,482) | (2,482) | (2,471) | | | Net Income Applicable To Common Shares | $2,061 | ($2,023) | ($13,428) | ($30,779) |
|
0.11% Nasdaq 
0.01%
Income Statement
